Grant: NOVADIGM THERAPEUTICS, INC.
NOVADIGM THERAPEUTICS, INC.
CDFA Program Title
Trans-NIH Recovery Act Research Support
Our Specific Aims are: 1. To establish Good Manufacturing Practice for the rAls3p-N vaccine candidate. GMP will be established by a contracting organization. Financing for GMP will occur over two calendar years. The GMP process will include technologic
Recipients Connected to Award
|NOVADIGM THERAPEUTICS, INC.||Primary recipient||$1,299,178.00|
|LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER||Sub-recipient||$690,572.00|
Vendors Connected to Award
|Althea Technologies, Inc.||Primary vendor||$36,750.00|
|MPI Research, Inc.||Primary vendor||$27,000.00|
|Althea Technologies, Inc.||Primary vendor||$76,700.00|
|Advanced BioScience Laboratories, Inc.||Primary vendor||$35,113.00|
|Althea Technologies, Inc.||Primary vendor||$33,000.00|